Skip to main content
Medical information Clinical review pending

Genetic Testing

MMP20 Gene Amelogenesis Imperfecta Type 2A2 Genetic Test

Genetic test for mutations in the MMP20 gene associated with Amelogenesis Imperfecta Type 2A2, a condition affecting dental enamel development. Helps identify genetic predisposition for tailored dental care.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample, Extracted DNA, or One drop of blood on FTA Card.
Results
Confirm with the laboratory before booking.
Preparation
A genetic counseling session is recommended before the test to discuss family history and create a pedigree chart. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the MMP20 Gene Amelogenesis Imperfecta Type 2A2 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of Amelogenesis Imperfecta.
  • ✓Symptoms of discolored, fragile, or sensitive teeth.
  • ✓Seeking genetic understanding of dental health issues.
  • ✓Diagnosis confirmation for enamel defects.
02

In plain language

What this test helps you understand

Identifies specific mutations in the MMP20 gene associated with Amelogenesis Imperfecta Type 2A2, aiding in diagnosis and understanding the genetic basis of enamel defects.
The MMP20 Gene Amelogenesis Imperfecta Type 2A2 NGS Genetic DNA Test is a diagnostic tool used to identify genetic mutations linked to amelogenesis imperfecta, a condition affecting dental enamel formation. This test uses Next-Generation Sequencing (NGS) technology for accurate results. Understanding your genetic factors is important for managing dental health effectively. This test specifically measures mutations in the MMP20 gene, crucial for enamel development. Detecting these mutations helps healthcare providers understand the cause of enamel defects and plan appropriate treatment. This test is recommended for individuals with a family history of amelogenesis imperfecta, those experiencing symptoms like discolored or fragile teeth, or anyone seeking a genetic understanding of their dental health. Taking this test provides accurate identification of genetic predispositions, supports informed decisions about dental care, and offers peace of mind by clarifying genetic risks. Results will indicate any detected mutations. A healthcare professional will help interpret the results and discuss implications for dental health and follow-up actions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA genetic counseling session is recommended before the test to discuss family history and create a pedigree chart. Confirm with the laboratory before booking.
SampleBlood sample, Extracted DNA, or One drop of blood on FTA Card.
MethodologyNext-Generation Sequencing (NGS) of the MMP20 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the MMP20 gene. Other genes can also cause Amelogenesis Imperfecta. A negative result does not completely rule out the condition. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

It is a genetic disorder affecting the development of dental enamel, leading to teeth that may be discolored, soft, or easily damaged.
Individuals with symptoms suggestive of amelogenesis imperfecta, a family history of the condition, or those seeking to understand the genetic cause of their dental issues.
The test analyzes a sample of your blood, extracted DNA, or a blood spot on an FTA card for specific mutations in the MMP20 gene.
A healthcare professional will explain the results, including whether any mutations in the MMP20 gene were found and what they mean for your dental health.
A genetic counseling session is recommended before the test to discuss your family history and the implications of the test results.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp